Skip to main content

Sex differences in the human metabolome



The sexual dimorphism represents one of the triggers of the metabolic disparities between the organisms, advising about wild implications in research or diagnostics contexts. Despite the mounting recognition of the importance of sex consideration in the biomedical fields, the identification of male- and female-specific metabolic signatures has not been achieved.

Main body

This review pointed the focus on the metabolic differences related to the sex, evidenced by metabolomics studies performed on healthy populations, with the leading aim of understanding how the sex influences the baseline metabolome. The main shared signatures and the apparent dissimilarities between males and females were extracted and highlighted from the metabolome of the most commonly analyzed biological fluids, such as serum, plasma, and urine. Furthermore, the influence of age and the significant interactions between sex and age have been taken into account.


The recognition of sex patterns in human metabolomics has been defined in diverse biofluids. The detection of sex- and age-related differences in the metabolome of healthy individuals are helpful for translational applications from the bench to the bedside to set targeted diagnostic and prevention approaches in the context of personalized medicine.

Graphical Abstract


  • Metabolomics is the gold-standard analytical approach to detect metabolic signatures in human biofluids.

  • Analyzing the metabolome at the baseline in healthy individuals is important to identify metabolite signatures to be attributed to one sex or both.

  • Differences in the metabolome of biofluids are sex- and age-dependent.

  • Sex is not still adequately considered in metabolomics-based investigations.


The influence of sexual dimorphism or gender-related dichotomies is gaining mounting interest among scientists in human/animal research or diagnostics fields. The scientific community commonly uses the terms sex and gender as interchangeable, even if they describe specific individual features. Gender specifically outlines the behavioral, psychological, and cultural features of an individual, referring to either social roles (gender role) or personal identification (gender identity). On the other hand, the sex of an individual groups the anatomy of its reproductive system, genitalia, and secondary sex characteristics, defining the elementary biological and dichotomous variables found in most living organisms. Without any social or behavioral consideration, sex represents the trigger of the metabolic disparities between the organisms [1,2,3,4].

Metabolomics is the systematic qualitative and quantitative study of the complete set of metabolites in a biological sample. As matter of fact, the metabolome is constituted by several different classes of “small molecules” (80–1200 Da molecular mass) with different chemical and physical properties. The metabolome includes amino acids, peptides, oligonucleotides, sugars, organic acids, ketones, aldehydes, lipids, steroids, alkaloids, xenobiotics, and the small molecules deriving from biosynthetic processes and cell reactions [5]. Metabolomics is able to provide information deriving from healthy and altered metabolic profiles, allowing to understand eventual pathophysiological conditions and the mechanisms that stand behind the metabolic disturbance [6,7,8,9,10,11,12,13,14].

The variations of the human metabolome might be influenced by numerous factors including methodological issues (i.e., sample collection and technical procedures), genetics, ethnicities, age, lifestyles, hormonal status, and sex [15,16,17,18]. The huge amount of data generated by the omics sciences requires particular attention in the steps of data analysis to ensure the accuracy of the results [19, 20]. Thus, the male and female metabolic phenotypes can be investigated through the in-depth analysis of the metabolome in biological fluids [16, 21,22,23,24,25].

In particular, in the current era of the precision medicine, the need to use the so-called “liquid biopsy” like easily accessible body fluids provides great advantages since the collection process is less invasive than tissue collection, and can be reiterated over the time in the processes of follow-up and real-time monitoring of the patients. In addition, the metabolites contained in the liquid biopsies have the power of mirroring multiple biochemical processes and pathways happening in tissues [26,27,28].

Research evidences endorse the strong differences existing between women and men in the incidence or severity of diseases, the metabolism, and the therapy owing to the different dosage or response to treatments [16, 17, 29,30,31]. However, many published studies did not stratify the data by sex and did not analyze the data by sex. Even from the current COVID-19 research are perceivable a scarce enrollment of women and a poor stratification of the subjects, and any further analysis based on the sex [32], providing collective results and conclusions valid for both the sexes [33, 34]. Furthermore, the sex differences found in the metabolome vary consistently across different age ranges, from infants to young adults, to the elderly [24, 35,36,37,38], underlining the importance of age in determining the sex differences. Finally, it is important to underline that the results based on one-sex analyses alone are not sufficient for drawing general conclusions to be extended to the whole population [39].

Therefore, in this article, the scientific literature was systematically reviewed to evaluate similarities and differences between the human male and female metabolomes of diverse biological fluids (plasma, serum, and urine). Due to the noteworthy technological innovations in metabolomics, the collection of studies published during the last 15 years of research would provide a step forward to understand how sex and age differentially influence the baseline metabolome in healthy individuals.

Materials and methods

The systematic review of the literature selected in this manuscript was carried out by following the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) system [40, 41].

Search strategy

The search of literature articles was performed in September 2021, using the MEDLINE/PubMed and ISI Web of Knowledge databases. The search was focused on three main fields/areas that included: (1) metabolomics, (2) sex/gender, (3) healthy populations. In particular, the search was conducted in both the databases using a combination of MeSH terms and variation terms for the above-mentioned fields, using the Boolean search operators “AND” and “OR”. The performed search was set as follows: “(metabolomics OR metabolome) AND (healthy individuals OR control OR sane OR children OR adults) AND (sex OR gender OR sex difference)”. The search looked at the articles published from 2005 to 2021.

Inclusion and exclusion criteria

The published studies selected by the search were first screened according to the information included in the title and the abstract. Two authors have performed this kind of work independently and then the results were matched. Then, the full-text version of the pertinent articles was taken into account for further consideration. The studies responding to the following criteria were considered: (i) human subjects as total or part of the samples analyzed; (ii) studies including only healthy individuals (or with the main focus on them); (iii) metabolomic analyses (by both NMR and MS techniques) performed on any biological matrix; (iv) articles with main focus on sex-related differences. Analyses performed on only one or few metabolites, on only one sex, lipidomics-based research, methods not based on MS or NMR technologies, articles including disease-state individuals or animal models or in vitro systems, non-English articles, review articles, book chapters, and editorials were excluded. Duplicate publications were deleted.

Data extraction

The data from the selected studies were extracted and reported, considering: the name of the first author, year of publication, country or ethnicity of the individuals, and the main characteristics of the subjects studied (such as sample size, sex/gender, age), the biological matrices used, and the analytical platforms employed for metabolomics analyses, including details of the downstream statistic tests.

Studies quality assessment

The quality assessment of the selected studies was performed by two authors independently, using a scoring system specifically created for this analysis (Additional file 1: Table S1). Then, the results were matched and compared for agreement. The studies were classified according to the scores as excellent (11–9), good (6–8), fair (5–4), and poor (< 4). Table 1 summarizes the variables of the score setting used to assess the quality of metabolomics data, according to the experimental design (considering the size and age stratification of the populations), the methodology (including the metabolomic platforms, the statistical analyses, and eventual validation experiments), and the novelty of the research. A score equal to or higher than 6 was considered a minimum for inclusion in the review. Few articles that were difficult to integrate or poorly focused on the main aim of this review were excluded despite the good attributed score.

Table 1 Classification of the 32 eligible studies selected for the review according to the score system


Literature search and selection process

The selection process of the articles searched in the literature is resumed in the flow diagram (Fig. 1). The literature search was performed using the MEDLINE/PubMed and ISI Web of Knowledge databases, leading to the identification of 1172 and 759 research records, respectively. During the screening process, the results from both the databases were merged, deleting the duplicate publications, and 32 articles were selected for the eligibility, undergoing full-text examination. Table 1 globally reports the scores attributed to each of the 32 studies according to pre-established criteria concerning the experimental design, methodology, and novelty of the research.

Fig. 1
figure 1

Schematic flow diagram of the entire review process

After full-text examination, 5 out of 32 studies [42,43,44,45,46] were excluded because the quality score was below 6. Despite the good scores, other 7 articles [47,48,49,50,51,52,53] were excluded because they were considered dispersive, or poorly focused on the main aim of this review work, which is to underline sex differences.

Finally, 20 articles [11, 18, 24, 25, 27, 43,44,45,46,47,48,49,50,51,52,53,54,55,56,57] were selected to be included in the review and summarized in Table 2, reporting the main characteristics retrieved from each manuscript. The 20 selected papers endorse different metabolomic approaches and different matrices, highlighting statistically significant sex-related differences in the plasma, serum, or urine metabolome of healthy patients. In addition, among them, 19 studies reported the age of the participants, with highly variable ranges going from 2 days to 100 years.

Table 2 Summary of the characteristics of the 20 studies included in the review

Overall, amino acids (AA), which included canonical AA, their derivatives and analogs, and acylcarnitines (AC) were the most frequently detected molecules in the majority of the works, probably because they are easily quantifiable by standardized targeted LC–MS/MS methods [4, 69,70,71,72]. Other metabolites such as OA or carbohydrates are more suitably identified by untargeted GC–MS or NMR-based approaches [73,74,75]. Consistently with these observations, we decided to not include specifically lipid molecules or lipidomics-based research in the analysis of sex differences and age to dedicate a specific space for lipids in future work.

Sex differences in the plasma metabolome

The plasma metabolome was analyzed and described in 7 out of 20 papers [55, 56, 62,63,64, 66, 68]. In particular, the sex differences in the plasma were investigated in the metabolome of healthy adult and old individuals, while one paper [64] focused on both boys and girls and their parents. All the main results are summarized in Table 3.

Table 3 Sex differences identified in the plasma metabolome for AA and AC

Overall, in adults, the changes are related to AA (and their derivatives). Most of the authors found higher levels of phenylalanine, glutamate [55, 63, 64], glutamine [63, 64, 66], kynurenine [55, 68], methionine [55, 64], proline [63, 64], and tyrosine [63, 64, 66] in men than in women. Also, the branched-chain amino acids (BCAA) namely valine, leucine, and isoleucine were found more abundant in men [56, 62,63,64, 66]. On the other hand, 3 articles (2 European and 1 Australian studies) showed that glycine was higher in females than in males [56, 64, 66]. No univocal results were found for tryptophan levels, however, the majority of studies found it increased in Caucasian, African-American, and Australian male adults [55, 64] while in the Hispanic population it was found higher or lower in Hispanic men compared to Hispanic women [55, 68]. Finally, creatinine displayed higher concentrations in men in all four the studies that detected this metabolite as differentially abundant between the sexes [55, 56, 62, 63]. Instead, creatine was identified in three out of the four studies as increased in women [55, 56, 63], whereas in Jovè’s study (see supplementary material of [68]) creatine seems to be upregulated in males.

The sole study performed on parents and their children [64] showed that children and adults present the following concordance: BCAA, citrulline, cysteine, phenylalanine, and tryptophan were higher in males, whereas glycine and serine were higher in females. Opposite variation trends were observed for alanine, glutamine, and OH-proline, being higher in male adults and female children.

Furthermore, Trabado and colleagues’ paper [62] was the only one that evidenced significantly changed plasma AC levels, with a significant increase of the small-chain AC, namely free carnitine (C0), propionylcarnitine (C3), and isovalerylcarnitine (C5) in men versus women [62]. A complete list of the full names for AC is reported in Additional file 1: Table S2.

Sex differences in the serum metabolome

Seven out of the 20 selected papers with a focus on the serum metabolome detected sex differences and the main findings for serum AA and AC are resumed in Tables 4 and 5, respectively. The high heterogeneity of the results observed was probably related to an effect due to the different ages of the selected cohorts. In particular, 2 publications were focused on cohorts of at-term and premature newborns [36, 57], 1 publication on children [54], and 4 articles on adult cohorts [15, 24, 38, 58].

Table 4 Sex differences identified in the serum metabolome for AA
Table 5 Sex differences identified in the serum metabolome for AC

In adults, Ruoppolo (2014) and Saito detected higher levels of methionine, asparagine, proline, tyrosine, glutamate, citrulline, and BCAA in men than in women [15, 58], whereas tryptophan was significantly lower and higher in men in [15] and [58], respectively. Mittelstrass and co-workers [24] found that serine and glycine were more abundant in adult women, whereas glutamine, ornithine, and arginine resulted higher in men. Dunn et al. described high levels of tyrosine in women, as well as methionine sulfoxide and caffeine [38]. In addition, Dunn et al. also found that serum creatinine levels were higher in females, and vice versa Saito detected increased levels for this metabolite in males [58].

In a single study performed on children (6–11 years), Lau et al. [54] discovered higher levels of serine, lysine, ornithine, and putrescine in girls, while serotonin was higher in boys.

Finally, Ruoppolo et al. [57] and Caterino et al. [36] found that both at-term female newborns and premature female infants had higher levels of alanine, aspartate, citrulline, glycine, and tyrosine.

The review of the serum metabolome retrieved some conflicting results on the sex-related distribution of AC, with most of the divergency accounting for a single-sex according to each author. Ruoppolo et al. [15] found that only C0 was higher in men than in women in the follicular phase. All the AC found by Saito [58] and Mittelstrass [24] displayed higher concentrations in male individuals. However, according to Lau et al. [54], the analysis of AC levels in children perceived higher levels in females.

In the cohort of male and female at-term newborns aged 48–72 h, Ruoppolo et al. [57] showed that the adjustment of metabolites levels for newborns' body weight modifies the sex differences displayed without. Body weight adjustment had an amplified effect on alanine, methionine, glycine, valine, and tyrosine that were maintained higher in female babies, whereas it overall reduced or eliminated the sex differences highlighted for AC, with some exceptions. Precisely, the levels of C0 and total esterified carnitine remained higher in male infants also after the adjustment for body weight. The levels of C8, C10, C12, C14, C16, C8DC, and C10DC were significantly higher in male infants, while C4 and C5 in female ones. Additionally, the sex differences in C4OH, C14OH, C16OH, C18:1OH were maintained in male infants, as well as for C10:1, C14:1, C16:1, C18:1, C18:2. On the other hand, the differences concerning C5:1, C6:1, C8:1, and C10:2 levels were accounted to female babies. At last, the second study by Caterino et al. [36] performed on DBS (dried blood spots) agreed with the increased levels of C18:1 and C18:2 in male infants as shown by Ruoppolo et al. [57]. Accordingly, also C2, C6, C18:1, C18:2, C4DC, and the total esterified carnitine were significantly higher in male infants.

Sex differences in the urine metabolome

Sex differences in the urine metabolome have been found in 9 publications [35, 54, 56, 59,60,61, 65,66,67]. In urine samples, the spectrum of the metabolite classes identified, including AA, AC, OA, carbohydrates, and other organic compounds, showed higher heterogeneity if compared to plasma or serum, with expected lower similarities within the selected articles. Tables 6 and 7 resume the sex-pattern recognition for the urinary metabolites described hereon.

Table 6 Sex differences identified in the urine metabolome (part 1)
Table 7 Sex differences identified in the urine metabolome (part 2)

Lau et al. showed sex differences in urine from children: isoleucine was increased in females, while 5-oxoproline and tyrosine were found at higher concentrations in males [54]. Caterino et al. discovered several sex differences by analyzing four age groups of infants from 1 to 36 months [35] (Additional file 1: Table S3), while Scalabre and colleagues did not find any sex-specific pattern in the urinary metabolome of infants under the age of 4 months [59].

In the adult population, a small number of AA was found divergent according to sex. In particular, proline [61], leucine [56], l-carnosine, and 2,6-diaminopimelic acid [66] were found increased in males, while higher concentrations of glycine [67] and other non-canonical AA (acetylphenylalanine, 2-aminoadipic acid, N-acetylaspartic acid, nicotinuric acid, aminosalicyluric acid) [61] were detected in females. Nonetheless, according to the findings reviewed from plasma and serum metabolomes, also the urinary metabolome appears to be characterized by an increased amount of creatinine in males [56, 60, 65] and creatine in females [60, 61, 65].

Essentially, the analysis of the AC levels has found the agreement of most of the selected papers for their distribution to one sex. In particular, AC molecules were higher in the male urine if compared to the female one [60, 61, 65], with exception of the methylglutarylcarnitine (C5-M-DC), which was higher in females [61].

An even higher heterogeneity was found concerning the sex differences accounting for the class of the OA. Precisely, several authors found in the female urine a specific increase in citric acid [56, 60, 61, 65, 67], fumaric acid [60, 61, 67], malic acid [61, 67], succinic acid, and 2-hydroxyglutaric acid [67], mevalonic acid, pyruvic acid, oxoglutaric acid, and pantothenic acid [61]. A divergence of α-ketoglutaric acid levels was accounted both for females [56, 61] and males [67]. Instead, several other OA were detected in the urine of males, such as stearic acid, pelargonic acid, heptadecanoic acid, caprylic acid, capric acid, 4-hydroxybutyric acid [67], 4-deoxythreonic acid, 2-hydroxyphenylacetic acid [56], and 3,4-dihydroxyphenylacetic acid [66].

Concerning the other classes of metabolites, the majority of carbohydrates were found in the urine of female individuals, such as d-fructose [56, 66], xylose, maltose, lyxose, galactonic acid [67], pentose, acetaminophen glucuronide, gluconic acid, glucuronic acid, threonic acid/erythronic acid, glyceric acid [61]. By contrast, UDP-glucuronic acid was present only in male urine [67].

Finally, Thévenot identified an entire group of acylglycines, including hippuric acid, 2-methylhippuric acid, p-hydroxyhippuric acid, tiglylglycine, cinnamoylglycine, 3-methylcrotonylglycine, valerylglycine, as more abundant in female urines, as well as for caffeine [61]. On the other hand, caffeine metabolites, namely 1-methylxanthine and 1-methylurate, were found higher in males by Chekmeneva [65].

Sex differences are age-dependent

The evaluation of the sex-related differences in the metabolome should take into account another important factor represented by the age, with males and females at different age stages possibly showing age-specific metabolic signatures. Among the selected articles, 11 of them identified age-dependent metabolomics profiles [18, 27, 44, 45, 47, 49,50,51,52,53, 57], but only 8 publications identified an interaction between sex and age or performed analyses for such evaluation [38, 55, 56, 58, 60, 61, 63, 68].

In detail, concerning the analyses of the plasma metabolome, Jovè and colleagues identified a significant separation between the age groups 30–49 years old and the 50–59 years old in females, while the 90–99 years age group was the only one that clustered in men, suggesting for a specific metabolic pattern for nonagenarian male subjects [68]. In addition, a significant interaction between age and sex was shown by Lawton and co-workers: in particular, urea and α-tocopherol significantly increased with the age more in females than in males, while the age-dependent increase in kynurenine and the age-dependent decrease in glycerol-3-phosphate were more pronounced in males [55]. Rist and colleagues observed that phosphate and methionine have generally higher plasma concentrations in younger men. In contrast, ornithine, tyrosine, isocitric acid, glucuronic acid, hippuric acid, choline, and pseudouridine have higher concentrations in older men. For women, the associations of the metabolite profiles with the age were less strong than for men. Ornithine, phenylalanine, glucose, mesoerythritol, glucuronic acid, hippuric acid, choline, and pseudouridine were higher in the plasma of older women, whereas isoleucine, tryptophan, aspartic acid, and malic acid tended to be higher in younger women [56]. Vignoli and colleagues reported greater age-related plasma differences in males than in females: histidine and acetate showed statistically higher concentrations in young males, while alanine and creatine were increased in old males. In females, glucose, glutamine, glycine, tyrosine, and creatine were statistically higher in old females [63].

With regard to the serum, Dunn et al. reported a significant interaction between sex and age for urate, glycerol, hexadecenoic acid, and caffeine [38]. The study by Saito et al. on the serum metabolome of two age-stratified (young and old) Japanese population revealed metabolites and metabolic pathways specifically associated with a single sex in both age ranges. In total, 158 and 130 metabolites showed a statistically significant difference between males and females in the young and old populations, respectively. Specifically, 138 and 113 metabolites were divergent in males in the young (25–35 years) and old (55–64 years) groups, respectively, while only 20 and 17 metabolites were more abundant in the female young (25–35 years) and old (55–65 years) populations, respectively. Moreover, 35 metabolites in males and 41 in females were increased in the young population when compared to the old, while 84 and 81 metabolites were more abundant in males and females, respectively, in the old than the young population [58].

Finally, in the analyses of the urinary metabolome, Rist and co-workers observed glutaric acid, 4-hydroxymandelic acid, N-acetylaspartic acid, creatinine, and sedoheptulose being higher in younger men, whereas hippuric acid, citric acid, 2,5-furandicarboxylic acid, 3-aminoisobutyric acid, and quinolinic acid showed higher concentrations in older men. On the other hand, glutaric acid, succinic acid, N-acetylaspartic acid, tiglylglycine, uracil, 1,5-anhydro-d-sorbitol, sedoheptulose, and creatinine were higher in younger women. By contrast, formic acid, tartaric acid, 2-O-methylascorbic acid, 2,5-furandicarboxylic acid, and 4-hydroxyphenyllactic acid were higher in older women [56]. Moreover, according to Slupsky and colleagues, alanine, trigonelline, carnitine, 3-hydroxy-isovalerate, and creatinine were significantly different between the younger and older groups both in the urine of men and women [60], while aspartic acid, oxoglutaric acid, malic acid, methylinosine, dimethylguanosine, aminosalicyluric acid, hydroxyanthranilic acid, 5-hydroxyindolacetic acid, threonic acid, and pyruvic acid showed a significant sex–age interaction in the analyses performed by Thevenot et al. [61].


The metabolomes of serum, plasma, and urine contain a multitude of molecules that can be intrinsic or extrinsic factors, of which most may have clinical relevance as used as biomarkers. Thus, metabolomics is easily included in any experimental design to provide support for disease diagnosis, and verify the severity and eventually the efficacy of treatments with the aim of transferring the metabolomics signatures into the clinical care, especially in the perspective of applying approaches to personalized medicine [76,77,78].

Here, we decided not to take into account the studies predominantly based on lipidomics investigations. Originally, the lipidome was considered a subcategory of the metabolome, being referred to as “the full characterization of lipid molecular species and their biological roles with respect to expression of proteins involved in lipid metabolism and function, including gene regulation” [79]. The huge biochemical complexity of lipids and the initial lack of analytical tools for their large-scale analysis have empowered the technologies behind lipid identification and quantification [79,80,81,82]. Thus, next to metabolomics, lipidomics science emerged as an additional discipline, deserving an appropriate space and independent consideration.

Globally, this systematic review attempted at categorizing the abundance of many metabolites to one sex or the other, also considering possible variations related to the age of the analyzed individuals. As demonstrated by the critical selection of only a small number of articles, our work showed that sex is not still adequately considered in metabolomics-based investigations, despite the mounting evidence of its clinical importance for diagnosis, therapy, and outcome [83]. In particular, the low number of eligible manuscripts that consider the baseline metabolome in healthy individuals, in combination with the high heterogeneity of their data owing to the different metabolomics platforms, statistical approach, and population size, have hindered any process of meta-analysis that was initially planned. Thus, we decided in the first instance to rely on the qualitative synthesis of the findings from each study. Nonetheless, the common tendency for each metabolite to be quantitatively more represented in one sex, according to authors' criteria, was considered. This allowed the semi-quantitative recognition of metabolites distribution across the sexes considering individuals within similar age ranges.

Thus, amongst the major sex-discriminatory metabolites, creatine was commonly identified as more abundant in females and creatinine as more abundant in male individuals, in all the biofluids analyzed and regardless of age. The amount of creatine and creatinine are often associated with the diet intake and the nutritional state, albeit creatine is also synthesized in vivo in the liver [84]. Creatine is detectable in multiple tissues, despite its concentrations and distributions vary consistently. Skeletal muscle, heart, and spermatozoa show the highest levels of creatine; an intermediate pool of creatinine is found in the brain, brown adipose tissue, and intestine, while low levels are tracked in lung, spleen, kidney, liver, white adipose tissue, and serum [84,85,86]. The levels of free creatine in vertebrates depend on the creatine kinase enzyme, which catalyzes the reversible transfer of the phosphate group from ATP to the creatine. The flexibility of creatine kinase in adapting its function according to the physiological state of each tissue is enabled by the energy demand [86]. According to the mounting consideration in the field of biochemistry of the relevance of the creatine/creatine kinase system for energy metabolism, sex differences lean toward an accumulation of creatine in female individuals. Besides a probable increased endogenous synthesis [60] and a lower creatine loss in females [84], this sex pattern might be also associated with the increased levels of circulating creatine kinase in males [87,88,89], which could diminish the amount of free creatine, enriching the pool of phosphocreatine.

The first step of creatine synthesis takes place in the kidney requiring glycine, methionine, and arginine. The entire glycine molecule is metabolized for the synthesis of creatine but only the methyl group from methionine and the amidino group from arginine are consumed [84]. While the latter amino acids showed from our review a distribution toward the male sex, glycine burden is predominant in females in all the biofluids analyzed, possibly justifying the need for a prompt synthesis of creatine.

The creatine synthesized de novo in the liver, together with the dietary creatine absorbed by the intestine, is transported through the blood to the creatine-requiring tissues, such as the muscle that takes up to 94% of the total creatine, being not able to make it by synthesis. The muscle creatine is non-enzymatically transformed into creatinine at a virtually steady rate (2% of the total creatine per day). Then, creatinine by diffusing out of the muscle cells is excreted by glomerular filtration into the urine [86]. Accordingly, we found a tendency of creatinine accumulation in biofluids from male individuals, including urine. Therefore, higher creatinine levels in men are reasonable considering that they are typically endowed with increased muscle mass than women.

Moreover, a robust tendency of BCAA to be distributed in the biofluids of male subjects was evidenced. As for creatinine, the differences in the muscle metabolism, muscle size, and the higher dietary protein intake of men may easily justify this tendency as compared to women [63].

In the mitochondria, the free carnitine can be conjugated to acyl-CoA molecules to produce AC, whose synthesis is sustained by the metabolism of fatty acids, AA, and glucose. Hence, the concentrations of circulating AC are dependent on the dietary regimen and may reflect the contribution of specific organs [90]. The levels of AC in the metabolomes analyzed in this review did not show a sharp sex distribution, despite only few authors found some AC predominantly increased in men biofluids. This could be partially legitimated by higher food intake in men. In addition, since AC variations are markers of metabolic and mitochondrial impairment in inborn errors of metabolism (including fatty acid β-oxidation disorders and organic acidemias, among others) [70, 91], and are associated with increased risk of obesity, type-2 diabetes, and cardiovascular diseases [90, 92, 93], individuals in a good healthy state may not show a significant sexual dimorphism in AC patterns.

Finally, the high heterogeneity of the organic compounds identified by each author, especially in urine, did not allow to track specific sex patterns for the majority of the metabolites here reviewed. Notwithstanding, citric acid levels were more elevated in women, as already accredited in the literature [56, 94,95,96]. Given that also other Krebs cycle intermediates, namely α-ketoglutaric acid and fumaric acid, showed sex divergency being increased in women, one may conceive of general sex differences in the Krebs cycle route, although the reason behind this explanation remains largely speculative [56].

What is more, here is provided some evidence that sex can highly affect the metabolome of diverse biological fluids in an age-dependent way, as already suggested for some serum or plasma biomarkers [97]. Indeed, from a critical analysis of our review work, the data here discussed present some variability in the metabolome of each biofluid analyzed, which could depend on the different age ranges of the participants. Hence, the sex stratification in every single class of age is highly advisable for the validation of reference values to increase their diagnostic and therapeutic appropriateness.

Moreover, we advise that different ethnicity, geographical localization, microbiome, and lifestyles such as the particular choice of foods or beverages, the smoking habit, and the use of hormonal therapies or other drugs are certainly able to differently influence the distribution of metabolites within both sexes. In fact, it is established that the serum metabolome of women is highly influenced by the sex hormones, including the exogenous hormones derived from oral contraceptives [15] or hormone replacement therapy, as well as the endogenous physiological changes occurring during menopause [98, 99].

In conclusion, sex and age should be strongly considered in the planning and the execution of metabolomic investigations, being such differences among the individuals the result of the influence of genome, transcriptome, and proteome. Thus, cumulative intrinsic and extrinsic factors affect the quantitative changes in the metabolome, differentially influencing the individual response of every single subject. Therefore, all the possible variables influencing the human metabolome should be carefully considered in order to reach an authentic personalized medicine.

Perspectives and significance

The outreach inspired by this review relies on the important consideration of sex patterns in all the aspects of research in health and disease, including metabolomics. In this review, several manuscripts were screened, but only a small number responded to the need of investigating the sex dichotomies in the metabolome of healthy subjects. Thus, we recognized that sex is not still adequately considered in metabolomics-based investigations. Historically, the female sex has been under-represented in both human and animal experimentations, being considered a confounding variable [83, 100]. This outlook can draw misleading evidences that are not equally applicable to both sexes. Accordingly, the same inaccurate interpretation of the results could follow when male- or female-dominant, and mixed-sex data are analyzed, giving rise to false positives and negatives accounting for one or the other sex, or masking existing differences [39].

Instead, nowadays, the differences between males and females undergo magnification, in order to understand the bases of sex dissimilarities [1]. This gains extreme power when healthy cohorts are analyzed, aiming at dissecting the differences in the metabolome at the baseline, and consequently acting on the bases of such considerations in the medical- or disease-related contexts. Thus, sex consideration should be encouraged in the phases of research planning and actuation, designing studies equally representing both sexes as subjects and eventually performing omics investigations in mixed-sex, and male- and female-separated cohorts [39]. The evidences reviewed in this manuscript do not allow drawing general and specific conclusions to be extended to the whole population. Nonetheless, strong indications were given on the sex-pattern recognition of several metabolites in men or women, which can help outlining the bases of future research.

Availability of data and materials

All data generated or analyzed during this study are included in this published article and its Additional files.



Analysis of variance


Analysis of covariance


Cerebrospinal fluid


Cross-validated ANOVA


Direct infusion


Dried blood spot




Flow injection analysis


Gas chromatography


Generalized linear model net


High-resolution mass spectrometry


Hydrophilic interaction liquid chromatography


Liquid chromatography




Mass spectrometry


Tandem mass spectrometry


Metabolome-wide association study


Nano-electrospray ionization


Nuclear magnetic resonance


Organic acids


Orthogonal projection to latent structures


Orthogonal partial least squares-discriminant analysis


Principal component analysis


Partial least square-discriminant analysis


Significance analysis of microarrays


Standard deviation


Statistical recoupling of variables


Support vector machine


Ultra (High) performance liquid chromatography


Variable importance on projection


  1. Audano M, Maldini M, De Fabiani E, Mitro N, Caruso D. Gender-related metabolomics and lipidomics: From experimental animal models to clinical evidence. J Proteomics. 2018;12:78.

    Google Scholar 

  2. Fausto-Sterling A. Gender/sex, sexual orientation, and identity are in the body: how did they get there? J Sex Res. 2019;56:529–55.

    Article  PubMed  Google Scholar 

  3. Cortright RN, Koves TR. Sex differences in substrate metabolism and energy homeostasis. Can J Appl Physiol. 2000;25:288.

    CAS  PubMed  Article  Google Scholar 

  4. Ruoppolo M, Caterino M, Albano L, Pecce R, Di Girolamo MG, Crisci D, et al. Targeted metabolomic profiling in rat tissues reveals sex differences. Sci Rep. 2018;8:4663.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  5. Noto A, Fanos V, Dessì A. Metabolomics in Newborns. Adv Clin Chem. 2016;34:8923.

    Google Scholar 

  6. Beger RD, Dunn W, Schmidt MA, Gross SS, Kirwan JA, Cascante M, et al. Metabolomics enables precision medicine: “A White Paper, Community Perspective.” Metabolomics. 2016;12:149.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. Beger RD, Schmidt MA, Kaddurah-Daouk R. Current concepts in pharmacometabolomics, biomarker discovery, and precision medicine. Metabolites. 2020;10:129.

    CAS  PubMed Central  Article  Google Scholar 

  8. Cacciatore S, Loda M. Innovation in metabolomics to improve personalized healthcare. Ann N Y Acad Sci. 2015;1346:57–62.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  9. Kastenmüller G, Raffler J, Gieger C, Suhre K. Genetics of human metabolism: an update. Hum Mol Genet. 2015;24:93–101.

    Article  CAS  Google Scholar 

  10. De Pasquale V, Costanzo M, Siciliano R, Mazzeo M, Pistorio V, Bianchi L, et al. Proteomic analysis of mucopolysaccharidosis IIIB mouse brain. Biomolecules. 2020;10:355.

    PubMed Central  Article  CAS  Google Scholar 

  11. Gonzalez Melo M, Fontana A, Viertl D, Allenbach G, Prior JO, Rotman S, et al. A knock-in rat model unravels acute and chronic renal toxicity in glutaric aciduria type I. Mol Genet Metab. 2021;12:78.

    Google Scholar 

  12. Gonzalez Melo M, Remacle N, Cudré-Cung H-P, Roux C, Poms M, Cudalbu C, et al. The first knock-in rat model for glutaric aciduria type I allows further insights into pathophysiology in brain and periphery. Mol Genet Metab. 2021;133:157–81.

    CAS  PubMed  Article  Google Scholar 

  13. Trupp M, Zhu H, Wikoff WR, Baillie RA, Zeng ZB, Karp PD, et al. Metabolomics reveals amino acids contribute to variation in response to simvastatin treatment. PLoS ONE. 2012;12:7.

    Google Scholar 

  14. Costanzo M, Cevenini A, Marchese E, Imperlini E, Raia M, Del Vecchio L, et al. Label-free quantitative proteomics in a methylmalonyl-coa mutase-silenced neuroblastoma cell line. Int J Mol Sci. 2018;19:3580.

    PubMed Central  Article  CAS  Google Scholar 

  15. Ruoppolo M, Campesi I, Scolamiero E, Pecce R, Caterino M, Cherchi S, et al. Serum metabolomic profiles suggest influence of sex and oral contraceptive use. Am J Transl Res. 2014;6:614.

    PubMed  PubMed Central  Google Scholar 

  16. Ramsey JM, Cooper JD, Penninx BWJH, Bahn S. Variation in serum biomarkers with sex and female hormonal status: Implications for clinical tests. Sci Rep. 2016;78:6.

    Google Scholar 

  17. Franconi F, Campesi I. Sex impact on biomarkers, pharmacokinetics and pharmacodynamics. Curr Med Chem. 2016;1:89.

    Google Scholar 

  18. Das M, Borah NC, Ghose M, Choudhury N. Reference ranges for serum uric acid among healthy Assamese people. Biochem Res Int. 2014;13:8.

    Google Scholar 

  19. Costanzo M, Fiocchetti M, Ascenzi P, Marino M, Caterino M, Ruoppolo M. Proteomic and bioinformatic investigation of altered pathways in neuroglobin-deficient breast cancer cells. Molecules. 2021;26:2397.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  20. Costanzo M, Caterino M, Cevenini A, Jung V, Chhuon C, Lipecka J, et al. Dataset of a comparative proteomics experiment in a methylmalonyl-CoA mutase knockout HEK 293 cell model. Data Br. 2020;33: 106453.

    Article  Google Scholar 

  21. Caterino M, Costanzo M, Fedele R, Cevenini A, Gelzo M, Di Minno A, et al. The serum metabolome of moderate and severe COVID-19 patients reflects possible liver alterations involving carbon and nitrogen metabolism. Int J Mol Sci. 2021;22:9548.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  22. Caterino M, Gelzo M, Sol S, Fedele R, Annunziata A, Calabrese C, et al. Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19. Sci Rep. 2021;11:2941.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. Ishikawa M, Maekawa K, Saito K, Senoo Y, Urata M, Murayama M, et al. Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects’ gender and age. PLoS ONE. 2014;78:6.

    Google Scholar 

  24. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 2011;7:e100725.

    Article  CAS  Google Scholar 

  25. Reuter SE, Evans AM, Chace DH, Fornasini G. Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann Clin Biochem. 2008;45:585.

    CAS  PubMed  Article  Google Scholar 

  26. Zhang Y, Wang Y, Su X, Wang P, Lin W. The value of circulating circular RNA in cancer diagnosis, monitoring, prognosis, and guiding treatment. Front Oncol. 2021.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Erben V, Poschet G, Schrotz-King P, Brenner H. Comparing metabolomics profiles in various types of liquid biopsies among screening participants with and without advanced colorectal neoplasms. Diagnostics. 2021;11:561.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  28. Ala-Korpela M, Kangas AJ, Soininen P. Quantitative high-throughput metabolomics: a new era in epidemiology and genetics. Genome Med. 2012;4:36.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  29. Mauvais-Jarvis F, Berthold HK, Campesi I, Carrero J-J, Dhakal S, Franconi F, et al. Sex- and Gender-Based Pharmacological Response to Drugs. Pharmacol Rev. 2021;73:730–62.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  30. Mauvais-Jarvis F, Bairey Merz N, Barnes PJ, Brinton RD, Carrero J-J, DeMeo DL, et al. Sex and gender: modifiers of health, disease, and medicine. Lancet. 2020;396:565–82.

    PubMed  PubMed Central  Article  Google Scholar 

  31. Legato MJ. Principles of Gender-Specific Medicine. Princ Gender-Specific Med. 2004;45:9.

    Google Scholar 

  32. Brady E, Nielsen MW, Andersen JP, Oertelt-Prigione S. Lack of consideration of sex and gender in COVID-19 clinical studies. Nat Commun. 2021;12:4015.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  33. Costanzo M, Caterino M, Fedele R, Cevenini A, Pontillo M, Barra L, et al. COVIDomics: the proteomic and metabolomic signatures of COVID-19. Int J Mol Sci. 2022;23:2414.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  34. Costanzo M, De Giglio MAR, Roviello GN. Anti-Coronavirus Vaccines: Past Investigations on SARS-CoV-1 and MERS-CoV, the Approved Vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under Development Against SARS-CoV-2 Infection. Curr Med Chem. 2021;28:87.

    Google Scholar 

  35. Caterino M, Ruoppolo M, Villani GRD, Marchese E, Costanzo M, Sotgiu G, et al. Influence of sex on urinary organic acids: a cross-sectional study in children. Int J Mol Sci. 2020;21:582.

    CAS  PubMed Central  Article  Google Scholar 

  36. Caterino M, Ruoppolo M, Costanzo M, Albano L, Crisci D, Sotgiu G, et al. Sex affects human premature neonates’ blood metabolome according to gestational age, parenteral nutrition, and caffeine treatment. Metabolites. 2021;11:158.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  37. Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M, et al. Meta-Analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet. 2009;5:e1000504.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  38. Dunn WB, Lin W, Broadhurst D, Begley P, Brown M, Zelena E, et al. Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics. 2014;45:8.

    Google Scholar 

  39. Bond KM, McCarthy MM, Rubin JB, Swanson KR. Molecular omics resources should require sex annotation: a call for action. Nat Methods. 2021;18:585–8.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  40. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ. 2009;89:2.

    Google Scholar 

  41. Siddaway AP, Wood AM, Hedges LV. How to do a systematic review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses. Annu Rev Psychol. 2019;45:9.

    Google Scholar 

  42. Reavis ZW, Mirjankar N, Sarangi S, Boyle SH, Kuhn CM, Matson WR, et al. Sex and race differences of cerebrospinal fluid metabolites in healthy individuals. Metabolomics. 2021;17:13.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  43. Takeda I, Stretch C, Barnaby P, Bhatnager K, Rankin K, Fub H, et al. Understanding the human salivary metabolome. NMR Biomed. 2009;22:577.

    CAS  PubMed  Article  Google Scholar 

  44. Jarrell ZR, Smith MR, Hu X, Orr M, Liu KH, Quyyumi AA, et al. Plasma acylcarnitine levels increase with healthy aging. Aging. 2020;12:13555.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. Hirschel J, Vogel M, Baber R, Garten A, Beuchel C, Dietz Y, et al. Relation of whole blood amino acid and acylcarnitine metabolome to age, sex, BMI, puberty, and metabolic markers in children and adolescents. Metabolites. 2020;12:89.

    Google Scholar 

  46. Das MK, Bishwal SC, Das A, Dabral D, Varshney A, Badireddy VK, et al. Investigation of gender-specific exhaled breath volatome in humans by GCxGC-TOF-MS. Anal Chem. 2014;86:1229.

    CAS  PubMed  Article  Google Scholar 

  47. Tsoukalas D, Alegakis A, Fragkiadaki P, Papakonstantinou E, Tsilimidos G, Geraci F, et al. Application of metabolomics part II: Focus on fatty acids and their metabolites in healthy adults. Int J Mol Med. 2018.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Bell JA, Santos Ferreira DL, Fraser A, Soares ALG, Howe LD, Lawlor DA, et al. Sex differences in systemic metabolites at four life stages: cohort study with repeated metabolomics. BMC Med. 2021;19:58.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  49. Zaura E, Brandt BW, Prodan A, TeixeiraDeMattos MJ, Imangaliyev S, Kool J, et al. On the ecosystemic network of saliva in healthy young adults. ISME J. 2017;11:1218.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  50. Li Z, Zhang Y, Hu T, Likhodii S, Sun G, Zhai G, et al. Differential metabolomics analysis allows characterization of diversity of metabolite networks between males and females. PLoS ONE. 2018;12:89.

    Google Scholar 

  51. Liang Q, Xu W, Hong Q, Xiao C, Yang L, Ma Z, et al. Rapid comparison of metabolites in humans and rats of different sexes using untargeted ultraperformance liquid chromatography coupled to time-of-flight mass spectrometry and an in-house software platform. Eur J Mass Spectrom. 2015;12:8.

    Google Scholar 

  52. Gallart-Ayala H, Konz I, Mehl F, Teav T, Oikonomidi A, Peyratout G, et al. A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects. Anal Chim Acta. 2018;78:12.

    Google Scholar 

  53. Yu Z, Zhai G, Singmann P, He Y, Xu T, Prehn C, et al. Human serum metabolic profiles are age dependent. Aging Cell. 2012;45:3.

    Google Scholar 

  54. Lau CHE, Siskos AP, Maitre L, Robinson O, Athersuch TJ, Want EJ, et al. Determinants of the urinary and serum metabolome in children from six European populations. BMC Med. 2018;5:89.

    Google Scholar 

  55. Lawton KA, Berger A, Mitchell M, Milgram KE, Evans AM, Guo L, et al. Analysis of the adult human plasma metabolome. Pharmacogenomics. 2008;4:8.

    Google Scholar 

  56. Rist MJ, Roth A, Frommherz L, Weinert CH, Krüger R, Merz B, et al. Metabolite patterns predicting sex and age in participants of the Karlsruhe Metabolomics and Nutrition (KarMeN) study. PLoS ONE. 2017;8:23.

    Google Scholar 

  57. Ruoppolo M, Scolamiero E, Caterino M, Mirisola V, Franconi F, Campesi I. Female and male human babies have distinct blood metabolomic patterns. Mol Biosyst. 2015;4:7863.

    Google Scholar 

  58. Saito K, Maekawa K, Kinchen JM, Tanaka R, Kumagai Y, Saito Y. Gender- and age-associated differences in serum metabolite profiles among Japanese populations. Biol Pharm Bull. 2016;1:9.

    Google Scholar 

  59. Scalabre A, Jobard E, Demède D, Gaillard S, Pontoizeau C, Mouriquand P, et al. Evolution of newborns’ urinary metabolomic profiles according to age and growth. J Proteome Res. 2017;34:e85.

    Google Scholar 

  60. Slupsky CM, Rankin KN, Wagner J, Fu H, Chang D, Weljie AM, et al. Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles. Anal Chem. 2007;3:366.

    Google Scholar 

  61. Thévenot EA, Roux A, Xu Y, Ezan E, Junot C. Analysis of the human adult urinary metabolome variations with age, body mass index, and gender by implementing a comprehensive workflow for univariate and OPLS Statistical Analyses. J Proteome Res. 2015;12:4.

    Google Scholar 

  62. Trabado S, Al-Salameh A, Croixmarie V, Masson P, Corruble E, Fève B, et al. The human plasma-metabolome: Reference values in 800 French healthy volunteers; Impact of cholesterol, gender and age. PLoS ONE. 2017;5:3.

    Google Scholar 

  63. Vignoli A, Tenori L, Luchinat C, Saccenti E. Age and sex effects on plasma metabolite association networks in healthy subjects. J Proteome Res. 2018;78:6.

    Google Scholar 

  64. Andraos S, Lange K, Clifford SA, Jones B, Thorstensen EB, Wake M, et al. Population epidemiology and concordance for plasma amino acids and precursors in 11–12-year-old children and their parents. Sci Rep. 2021;11:3619.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  65. Chekmeneva E, Dos Santos CG, Gómez-Romero M, Stamler J, Chan Q, Elliott P, et al. Ultra-performance liquid chromatography-high-resolution mass spectrometry and direct infusion-high-resolution mass spectrometry for combined exploratory and targeted metabolic profiling of human urine. J Proteome Res. 2018;23:555.

    Google Scholar 

  66. De Paepe E, Van Meulebroek L, Rombouts C, Huysman S, Verplanken K, Lapauw B, et al. A validated multi-matrix platform for metabolomic fingerprinting of human urine, feces and plasma using ultra-high performance liquid-chromatography coupled to hybrid orbitrap high-resolution mass spectrometry. Anal Chim Acta. 2018;2:45.

    Google Scholar 

  67. Fan S, Yeon A, Shahid M, Anger JT, Eilber KS, Fiehn O, et al. Sex-associated differences in baseline urinary metabolites of healthy adults. Sci Rep. 2018;1:3.

    Google Scholar 

  68. Jové M, Maté I, Naudí A, Mota-Martorell N, Portero-Otín M, De La Fuente M, et al. Human aging is a metabolome-related matter of gender. J Gerontol Ser A Biol Sci Med Sci. 2016;18:78.

    Google Scholar 

  69. De Pasquale V, Caterino M, Costanzo M, Fedele R, Ruoppolo M, Pavone LM. Targeted metabolomic analysis of a mucopolysaccharidosis IIIB mouse model reveals an imbalance of branched-chain amino acid and fatty acid metabolism. Int J Mol Sci. 2020;23:78.

    Google Scholar 

  70. Giacco A, Delli Paoli G, Senese R, Cioffi F, Silvestri E, Moreno M, et al. The saturation degree of fatty acids and their derived acylcarnitines determines the direct effect of metabolically active thyroid hormones on insulin sensitivity in skeletal muscle cells. FASEB J. 2019;33:1811–23.

    CAS  Article  PubMed  Google Scholar 

  71. Horakova O, Hansikova J, Bardova K, Gardlo A, Rombaldova M, Kuda O, et al. Plasma acylcarnitines and amino acid levels as an early complex biomarker of propensity to high-fat diet-induced obesity in mice. PLoS ONE. 2016;12:8.

    Google Scholar 

  72. Costanzo M, Caterino M, Cevenini A, Jung V, Chhuon C, Lipecka J, et al. Proteomics reveals that methylmalonyl-coa mutase modulates cell architecture and increases susceptibility to stress. Int J Mol Sci. 2020;21:4998.

    CAS  PubMed Central  Article  Google Scholar 

  73. Christou C, Gika HG, Raikos N, Theodoridis G. GC-MS analysis of organic acids in human urine in clinical settings: A study of derivatization and other analytical parameters. J Chromatogr B Anal Technol Biomed Life Sci. 2014;1:9.

    Google Scholar 

  74. Jones PM, Bennett MJ. Urine organic acid analysis for inherited metabolic disease using gas chromatography-mass spectrometry. Methods Mol Biol. 2010;2:56.

    Google Scholar 

  75. Lubes G, Goodarzi M. GC–MS based metabolomics used for the identification of cancer volatile organic compounds as biomarkers. J Pharm Biomed Anal. 2018;5:78.

    Google Scholar 

  76. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, et al. The Human Serum Metabolome. PLoS ONE. 2011;6:e16957.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  77. Castelli FA, Rosati G, Moguet C, Fuentes C, Marrugo-Ramírez J, Lefebvre T, et al. Metabolomics for personalized medicine: the input of analytical chemistry from biomarker discovery to point-of-care tests. Anal Bioanal Chem. 2021.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Di Minno A, Gelzo M, Caterino M, Costanzo M, Ruoppolo M, Castaldo G. Challenges in metabolomics-based tests, biomarkers revealed by metabolomic analysis, and the promise of the application of metabolomics in precision medicine. Int J Mol Sci. 2022;23:5213.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  79. Lagarde M, Géloën A, Record M, Vance D, Spener F. Lipidomics is emerging. Biochim Biophys Acta Mol Cell Biol Lipids. 2003;1634:61.

    CAS  Article  Google Scholar 

  80. Harrieder E-M, Kretschmer F, Böcker S, Witting M. Current state-of-the-art of separation methods used in LC-MS based metabolomics and lipidomics. J Chromatogr B. 2022;1188: 123069.

    CAS  Article  Google Scholar 

  81. Han X, Gross RW. The foundations and development of lipidomics. J Lipid Res. 2022;63: 100164.

    CAS  PubMed  Article  Google Scholar 

  82. Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov. 2005;4:594–610.

    CAS  PubMed  Article  Google Scholar 

  83. Campesi I, Montella A, Seghieri G, Franconi F. The person’s care requires a sex and gender approach. J Clin Med. 2021;10:4770.

    PubMed  PubMed Central  Article  Google Scholar 

  84. Brosnan JT, da Silva RP, Brosnan ME. The metabolic burden of creatine synthesis. Amino Acids. 2011;40:1325–31.

    CAS  Article  PubMed  Google Scholar 

  85. Brosnan ME, Brosnan JT. The role of dietary creatine. Amino Acids. 2016;48:1785–91.

    CAS  Article  PubMed  Google Scholar 

  86. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev. 2000;80:1107–213.

    CAS  Article  PubMed  Google Scholar 

  87. Norton JP, Clarkson PM, Graves JE, Litchfield P, Kirwan J. Serum creatine kinase activity and body composition in males and females. Hum Biol. 1985;57:591–8.

    CAS  PubMed  Google Scholar 

  88. Yen C-H, Wang K-T, Lee P-Y, Liu C-C, Hsieh Y-C, Kuo J-Y, et al. Gender-differences in the associations between circulating creatine kinase, blood pressure, body mass and non-alcoholic fatty liver disease in asymptomatic asians. PLoS ONE. 2017;12:e0179898.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  89. Neal RC, Ferdinand KC, Yčas J, Miller E. Relationship of ethnic origin, gender, and age to blood creatine kinase levels. Am J Med. 2009;122:73–8.

    CAS  PubMed  Article  Google Scholar 

  90. Makrecka-Kuka M, Sevostjanovs E, Vilks K, Volska K, Antone U, Kuka J, et al. Plasma acylcarnitine concentrations reflect the acylcarnitine profile in cardiac tissues. Sci Rep. 2017;7:17528.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  91. Ruiz-Sala P, Peña-Quintana L. Biochemical markers for the diagnosis of mitochondrial fatty acid oxidation diseases. J Clin Med. 2021;10:4855.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  92. Caballero FF, Struijk EA, Lana A, Buño A, Rodríguez-Artalejo F, Lopez-Garcia E. Plasma acylcarnitines and risk of lower-extremity functional impairment in older adults: a nested case–control study. Sci Rep. 2021;11:3350.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  93. Reuter SE, Evans AM. Carnitine and Acylcarnitines. Clin Pharmacokinet. 2012;51:553–72.

    CAS  Article  PubMed  Google Scholar 

  94. Kochhar S, Jacobs DM, Ramadan Z, Berruex F, Fuerholz A, Fay LB. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal Biochem. 2006;352:274–81.

    CAS  PubMed  Article  Google Scholar 

  95. Saude EJ, Adamko D, Rowe BH, Marrie T, Sykes BD. Variation of metabolites in normal human urine. Metabolomics. 2007;3:439–51.

    CAS  Article  Google Scholar 

  96. Psihogios NG, Gazi IF, Elisaf MS, Seferiadis KI, Bairaktari ET. Gender-related and age-related urinalysis of healthy subjects by NMR-based metabonomics. NMR Biomed. 2008;21:195–207.

    CAS  Article  PubMed  Google Scholar 

  97. Campesi I, Occhioni S, Tonolo G, Cherchi S, Basili S, Carru C, et al. Ageing/menopausal status in healthy women and ageing in healthy men differently affect cardiometabolic parameters. Int J Med Sci. 2016;13:124–32.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  98. Moyer AM, Matey ET, Miller VM. Individualized medicine: Sex, hormones, genetics, and adverse drug reactions. Pharmacol Res Perspect. 2019.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Balasubramanian R, Demler O, Guasch-Ferré M, Paynter NP, Sheehan R, Liu S, et al. Metabolomic effects of hormone therapy and associations with coronary heart disease among postmenopausal women. Circ Genomic Precis Med. 2020.

    Article  Google Scholar 

  100. Franconi F, Campesi I, Colombo D, Antonini P. Sex-gender variable: methodological recommendations for increasing scientific value of clinical studies. Cells. 2019;8:476.

    PubMed Central  Article  Google Scholar 

Download references


Not applicable.


No funding was provided for the present work.

Author information

Authors and Affiliations



MCo performed formal analysis, wrote, reviewed, and edited the original manuscript. MCa curated the data and reviewed the manuscript. GS provided statistical support and reviewed the manuscript. MR and FF conceptualized and supervised the study. IC supervised the study and reviewed the original manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Michele Costanzo.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Table S1.

Score setting for quality assessment of metabolomics studies. Table S2. A list with the complete names of all the AC described in this review. Table S3. Sex differences identified by Caterino et al. [35] in the urinary organic acids of 4 age groups of infants-to-children individuals.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Costanzo, M., Caterino, M., Sotgiu, G. et al. Sex differences in the human metabolome. Biol Sex Differ 13, 30 (2022).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Metabolomics
  • Sex differences
  • Age
  • Metabolic signature
  • Liquid biopsy
  • Biomarkers